Live Breaking News & Updates on Paula Schweitzer

Stay updated with breaking news from Paula schweitzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Paula Schweitzer, PhD: AD109 Demonstrates Significant Reduction of AHI4

Promising results from the ATS Conference suggest that AD109, an oral treatment for obstructive sleep apnea, demonstrated significant reduction of AHI and potential mitigation of daytime fatigue.

....

United States , Paula Schweitzer , American Thoracic Society , Research Center , International Conference , Sleep Medicine ,

Apnimed Presents Positive Results of Sleep Apnea Drug Candidate

Apnimed presented positive results from its phase 2b trial of a drug candidate to treat sleep apnea at the ATS 2023 International Conference. ....

Paula Schweitzer , Larry Miller , International Conference , Drug Administration , Research Center , Sleep Medicine , Fast Track ,

Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023

Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Larry Miller , Amanda Breedingscient , Paula Schweitzer , Research Center , International Conference , Apnimed Inc , Drug Administration , Research At St , Data Showed , Significantly Improved , Both Objective , Subjective Outcomes , Support Advancing , Breaking News , Apnea Hypopnea Index , Sleep Medicine , Chief Executive Officer , Total Sleep Time , Fast Track , Sleep Apnea , Wendy Gabelkendall Investor ,

Paula Schweitzer, PhD: ATS Data Support Oral Treatment for Obstructive Sleep Apnea

AD109 shows the potential to address an unmet need in obstructive sleep apnea treatment. ....

United States , Paula Schweitzer , International Conference , Research Center , American Thoracic Society , Sleep Medicine , Apnea Hypopnea Index ,

Apnimed to Present Data on Drug Candidate for Sleep Apnea

Data from Apnimed’s MARIPOSA phase 2b trial of its drug candidate for OSA will be featured at the ATS 2023 International Conference. ....

United States , Larry Miller , Paula Schweitzer , Huy Pho , Research Center , International Conference , Waltere Washington Convention Center , Drug Administration , American Thoracic Society , Horal Agent , Subjective Outcomes , Obstructive Sleep Apnea , Controlled Clinical , Breaking News , New Approaches , New Trials Mini Symposium , Convention Center , Sleep Medicine , Inter Scorer Variability , Different Indices , Obstructive Sleep Apnea Severity , Advanced Signal Anaylsis , New Diagnostics , Physiologic Insights , Street Level , Clinical Data Scientist ,